Cardiac tachyarrhythmia therapy selection based on patient response information

• US 7,725,184 B2
• Filed: 05/30/2007
• Issued: 05/25/2010
• Est. Priority Date: 11/23/2004
• Status: Expired due to Fees

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Cazares, Shelley Marie
• Primary Examiner(s): Layno; Carl H
• Assistant Examiner(s): MALAMUD, DEBORAH LESLIE
• Application Number:
  US11/807,696
• Publication Number:
  US 20070239217A1
• Time in Patent Office: 1,091 Days
• Field of Search: 600509-510, 600/518, 607/4, 607/9, 607/14
• US Class Current: 607/14
• CPC Class Codes: A61B 5/35 by template matching
• CPC Class Codes: A61B 5/361 Detecting fibrillation
• CPC Class Codes: A61B 5/363 Detecting tachycardia or bradycardia
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/365 controlled by a physiological parameter, e.g. heart potential evoked response A61N1/371
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

Cardiac treatment methods and devices providing templates representative of past tachyarrhythmia events, each template associated with a therapy. A cardiac waveform is detected, and if it corresponds to a particular template associated with a previous therapy that was satisfactory in terminating a past event, the previous therapy is delivered again. If unsatisfactory, the previous therapy is eliminated as an option. If, for example, the previous therapy was an antitachycardia pacing therapy unsatisfactory in terminating the past tachyarrhythmia event, delivery of the antitachycardia pacing therapy is eliminated as an option. Instead of ATP therapy, one or more of a cardioversion, defibrillation, or alternate anti-tachycardia pacing therapy may be associated with the particular template. Cardiac waveforms and templates may correspond in terms of one or more of morphology, timing, drug regimen, medication, neural activity, patient activity, hemodynamic status, cardiac tissue impedance, transthoracic impedance, or other information corresponding to the episode.

Claims

1. A method, comprising:

providing one or more templates representative of one or more of a patient'"'"'s past tachyarrhythmia events, the one or more templates associated in memory with a therapy to treat tachyarrhythmia events;

detecting a cardiac waveform;

matching a particular template of the one or more templates with the cardiac waveform;

delivering the therapy based on the match between the particular template and the cardiac waveform; and

determining whether the therapy was unsatisfactory in terminating an arrhythmia associated with the particular template and, if the therapy is determined unsatisfactory, eliminating the therapy as an option for treating a subsequent tachyarrhythmia event associated in memory with the particular template and associating in memory the particular template with a new therapy.

2. The method of claim 1, wherein if the therapy was an antitachycardia pacing therapy determined to be unsatisfactory in terminating the tachyarrhythmia event, eliminating delivery of the antitachycardia pacing therapy as an option for treating a subsequent tachyarrhythmia event and associating one or more of a cardioversion, a defibrillation therapy, or an alternate anti-tachycardia pacing therapy with the particular template.

3. The method of claim 1, wherein the matching between the cardiac waveform and the particular template is a correspondence in terms of morphology.

4. The method of claim 1, wherein the matching between the cardiac waveform and the particular template is a correspondence in terms of timing.

5. The method of claim 1, wherein the matching between the cardiac waveform and the particular template is a correspondence in terms of a) drug regimen and morphology or b) drug regimen and timing.

6. The method of claim 1, comprising adding a new template to the one or more templates by replacing an oldest template of the one or more templates with the new template.

7. The method of claim 1, comprising associating one or more of medication information, neural activity information, patient activity information, hemodynamic status information, cardiac tissue impedance information, and transthoracic impedance information with the one or more templates.

8. The method of claim 1, comprising deleting a particular template of the one or more templates if the particular template is older than a predetermined age, or has not matched to a cardiac waveform for a predetermined time, or has matched to past arrhythmias least frequently relative to other templates, or represents a heart-rate similar to other existing templates.

9. The method of claim 1, comprising deleting a particular template of the one or more templates if the particular template is associated with a drug regimen that no longer matches the patient'"'"'s current drug regimen.

10. The method of claim 1, wherein the detected cardiac waveform is indicative of an arrhythmia in the ventricles, of ventricular or supra-ventricular origin.

11. The method of claim 1, wherein the detected cardiac waveform is indicative of an arrhythmia in the atria.

12. The method of claim 1, further comprising arbitrating between two or more templates if the cardiac waveform matches two or more templates.

13. The method of claim 1, further comprising, if the cardiac waveform matches two or more templates:

selecting a template of the two or more templates associated with a treatment satisfactory in terminating the tachyarrhythmia event, and delivering its associated tachyarrhythmia therapy;

or

selecting a most recently used or generated template associated with a treatment satisfactory in terminating the tachyarrhythmia event, and delivering its associated tachyarrhythmia therapy;

or

selecting the most frequently matched template associated with a treatment satisfactory in terminating the tachyarrhythmia event, and delivering its associated tachyarrhythmia therapy;

or

selecting the template associated with a treatment satisfactory in terminating the tachyarrhythmia event whose rate information most closely corresponds to the detected cardiac waveform, and delivering its associated tachyarrhythmia therapy;

or

selecting the template associated with one or more of a patient'"'"'s drug regimen, neural activity, patient activity, hemodynamic state, transthoracic impedance, and cardiac tissue impedance similar to the patient'"'"'s current status.

14. The method of claim 1, wherein the new therapy comprises an anti-tachycardia pacing therapy of substantially equivalent aggression in terms of energy or coupling interval.

15. The method of claim 1, wherein the new therapy comprises an anti-tachycardia pacing therapy of greater aggression in terms of energy or coupling interval.

16. The method of claim 1, wherein the new therapy comprises a cardioversion or defibrillation therapy.

17. A medical system, comprising:

a cardiac therapy system configured to deliver a cardiac therapy to a patient;

a detector system configured to detect a cardiac waveform associated with a tachyarrhythmia;

therapy delivery circuitry configured to deliver one or more therapies to treat tachyarrhythmia events; and

a template processor and memory coupled to the detector system and the cardiac therapy system, the template processor and memory configured to store one or more templates representative of one or more of a patient'"'"'s past tachyarrhythmia events, the one or more templates associated in memory with the one or more therapies, match a particular template of the one or more templates with the cardiac waveform, facilitate delivery of a therapy of the one or more therapies by the therapy delivery circuitry based on the match between the particular template and the cardiac waveform, determine whether the therapy was satisfactory in terminating an arrhythmia associated with the particular template and if the therapy is determined unsatisfactory, eliminate the therapy as an option for treating a subsequent tachyarrhythmia event associated with the particular template and associate the particular template with a new therapy.

18. The system of claim 17, wherein the cardiac therapy system is configured to deliver an anti-tachycardia pacing therapy to the patient to treat the tachyarrhythmia and determine one or both of the effectiveness and satisfaction of the anti-tachycardia pacing therapy.

19. The system of claim 17, comprising a patient activity sensor configured to provide patient activity information associated with tachyarrhythmia episodes to the template processor.

20. The system of claim 17, comprising a neural activity sensor configured to provide patient neural activity information associated with tachyarrhythmia episodes to the template processor.

21. The system of claim 17, comprising a transthoracic impedance sensor configured to provide patient transthoracic impedance information associated with tachyarrhythmia episodes to the template processor.

22. The system of claim 17, comprising an accelerometer configured to provide acceleration information associated with tachyarrhythmia episodes to the template processor.

23. The system of claim 17, comprising a cardiac tissue impedance sensing system configured to provide patient cardiac tissue impedance information associated with tachyarrhythmia episodes to the template processor.

24. The system of claim 17, comprising a hemodynamic status sensor configured to provide patient hemodynamic status information associated with tachyarrhythmia episodes.